P005672 HCl 25mg 25mg | Purity Not Available
Adooq Bioscience
P005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageP005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageP005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PagePR-171 (Carfilzomib) is a tetrapeptide epoxyketone and a selective proteasome inhibitor. It is an analog of epoxomicin.
More Information Supplier PagePR-171 (Carfilzomib) is a tetrapeptide epoxyketone and a selective proteasome inhibitor. It is an analog of epoxomicin.
More Information Supplier PageCefozopran is a fourth-generation cephalosporin. It would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.
More Information Supplier PageCefozopran is a fourth-generation cephalosporin. It would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.
More Information Supplier Page